The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Cardinal Health
Stock and Other Ownership Interests - Cardinal Health
Real-world (RW) characteristics, treatment patterns, and outcomes of patients with cholangiocarcinoma (CCA) treated with pemigatinib.
 
Kim Saverno
Employment - Incyte
Stock and Other Ownership Interests - Incyte
 
Cherrishe Brown-Bickerstaff
Employment - Cardinal Health
Research Funding - Ascentage Pharma (Inst); Blue Note Therapeutics; Bristol Myers Squibb (Inst); Celgene/Bristol-Myers Squibb (Inst); Daiichi Sankyo/Lilly (Inst); Eisai (Inst); EmitBio (Inst); Greenwich Biosciences (Inst); Incyte (Inst); Pfizer (Inst)
 
Angele Kotomale
No Relationships to Disclose
 
Michael A. Rodriguez
Employment - Incyte
Stock and Other Ownership Interests - Incyte
 
Bruce A. Feinberg
Employment - Cardinal Health
Leadership - Cardinal Health
Stock and Other Ownership Interests - Cardinal Health
 
Sarah Gordon
No Relationships to Disclose
 
Haobo Ren
Employment - Incyte
Stock and Other Ownership Interests - Incyte
 
Evan Mark Braunstein
Employment - Incyte
Stock and Other Ownership Interests - Incyte
 
Richard D. Kim
Consulting or Advisory Role - Abbvie; AstraZeneca; Exelixis; Pfizer; Roche/Genentech; SERVIER; Taiho Oncology
Speakers' Bureau - AstraZeneca; Incyte